| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;50:630.)
© 2007 American Heart Association, Inc.
Original Articles |
From the Departments of Anesthesiology and Critical Care Medicine (A.B., D.F., C.W.H., D.A., A.K., D.E.B., D.N.), Biostatistics (R.E.T.), Cardiology (G.G.), and Cardiac Surgery (A.S.), Johns Hopkins Medical Institutions and Bloomberg School of Public Health (R.E.T.), Baltimore, Md.
Correspondence to Daniel Nyhan, Anesthesiology, Tower 711, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287. E-mail dnyhan{at}jhmi.edu
| Abstract |
|---|
|
|
|---|
Key Words: clinical science cardiac surgery pulse pressures stroke hypertension
| Introduction |
|---|
|
|
|---|
Age-related vascular changes are manifest as increased vascular stiffness, a variable that has emerged as a critical feature of vascular aging and an independent risk factor for cardiovascular disease.7–9 Central vascular stiffness is a function of the aorta and its main branches, which are embryologically and structurally distinguishable from distal arteries and arterioles.10,11 Physiologically, central vessels function not only to cushion and dampen the pressure oscillations produced by ventricular ejection but also to transfer energy and mechanical signals along the vasculature. The latter consists of propagated waves that are reflected at points of structural or functional discontinuity in the arterial tree.9 Antegrade/incident and retrograde/reflected waves contribute to the actual arterial pressure waveform. In a compliant, nonstiff, usually young vasculature, the reflected wave returns to the central circulation during diastole, augmenting diastolic myocardial perfusion. In contrast, in a stiff, usually elderly vasculature, the reflected wave returns to the central circulation during systole, amplifying systolic aortic and ventricular pressures. These hemodynamic developments result in increased ventricular loading conditions12–14 and in compromised vital organ perfusion. Vascular stiffness is, thus, manifest as increased systolic blood pressure, increased pulse pressure (PP), or increased pulse wave velocity,7–9,15–17 each of which has been used in studies of vascular stiffness.6,8,15 Peripheral pressures, eg, brachial PP, are not the same as central pressures and are greater than central PPs in a young compliant vasculature, but central PPs increase and may equalize peripheral PPs in a stiff vasculature. The influence of vascular stiffness on outcome after cardiac surgery has not been investigated previously. In this retrospective review, we used peripheral (brachial) PP as an index of vascular stiffness and determined its influence on stroke development.
| Methods |
|---|
|
|
|---|
1 day existed between catheterization and the patients subsequent cardiac surgery. Stroke was defined as a new, nonreversible focal neurologic deficit, diagnosed clinically by a neurologist with or without confirmation by brain imaging.
Statistical Analysis
In initial confirmatory analyses, group differences were statistically assessed by the Students 2-sample t test for continuous measures and the
2 goodness-of-fit test for categorical data. Logistic models were used to calculate both the unadjusted and adjusted odds ratio of stroke for the independent predictors. "Stroke-free" survival curves were constructed using the method of Kaplan–Meier, whereas the unadjusted and adjusted hazards ratios of stroke were calculated using the Cox proportional-hazards regression model. Differences in survival functions by group were assessed by the log-rank test. All analyses were performed using the statistical software package STATA 9.0 (Stat Corp).
| Results |
|---|
|
|
|---|
|
Forty-two patients (6%) had a postoperative stroke, all of which occurred within 30 days of surgery. Of the stroke patients, 7 (16.7%) died compared with 54 deaths (8.2%) among the nonstroke patients (P=0.058). Stroke occurred in 8.8% of women compared with a stroke incidence of 4.7% for men (P=0.034). Importantly, stroke patients were not significantly (P=0.481) older than patients who did not have strokes.
Stroke patients had a higher mean PP than those without stroke (81.2 mm Hg versus 64.5 mm Hg; P=0.0006). Based on the logistic regression analysis model, PP was an independent predictor of stroke (unadjusted odds ratio: 1.35; 95% CI: 1.13 to 1.62 for every 10 mm Hg increase in PP; P=0.001; Figure 1).
|
Table 2 shows the hazard ratio (HR) and CI for the unadjusted and adjusted Cox models. The adjusted model includes those variables with a P value of
0.10 associated with the unadjusted HR. Because it was a variable of interest, chronological age was included in the adjusted model regardless of significance in the unadjusted case. Increases in brachial PP were associated with an increased risk of stroke development (HR: 1.32; 95% CI: 1.12 to 1.57 for each 10 mm Hg increase in PP; P<0.001, unadjusted model). This relationship remained highly significant (HR: 2.62; 95% CI: 1.49 to 4.60 for each 10 mm Hg increase in PP; P<0.001) in the adjusted model, which included age. A likelihood ratio test of the adjusted model above with and without peripheral (brachial) PP found that this variable made a highly statistically significant contribution to the hazards of stroke (
21=11.54; P=0.0007). In the adjusted model, ejection fraction was inversely related to stroke (HR: 0.52; 95% CI: 0.35 to 0.78; P=0.002).
|
Figure 2 illustrates the Kaplan–Meier estimates of the stroke-free survival by days postsurgery for those with a PP of <72 mm Hg versus >72 mm Hg. The difference in stroke-free survival was significant between the low and high PP groups, as determined by the log-rank test (P=0.0067). This cutoff value was chosen based on the receiver operator curve analyses from the logistic regression model. The cut point of 72 mm Hg gave an optimal sensitivity and specificity of 71.4% and 66.2%, respectively, and a corresponding receiver operator curve value of 0.714.
|
In individuals with a compliant vasculature, peripheral PPs are greater than central PPs. With increasing central vascular stiffness, central pressures increase and can equal or sometimes exceed peripheral pressures. Figure 3 illustrates the relationship between peripheral (brachial) and central aortic PP in patients (n=339) in whom both measurements were available. These 2 values were highly correlated (r2=0.465). This suggests that peripheral PP reflects central PP in these patients and that there is a convergence of these 2 PP values.
|
| Discussion |
|---|
|
|
|---|
Because of a growing number of aged and high-risk patients, there is an increasing emphasis on perioperative complications and outcomes after cardiac surgery.1 A better understanding of risk factors might not only provide a more effective method for assessing the risks versus benefits of surgery for an individual but also foster the development of preventative strategies. Neurologic complications manifest as stroke and neurocognitive dysfunction are of particular concern, because they are associated with longer hospitalization, higher frequency of discharge to secondary care facilities, altered quality of life, and mortality.20–22 Neurologic complications were responsible for 7.2% of all deaths after cardiac surgery in the 1970s,
20% of deaths in the 1980s, and the number continues to increase.23,24 Previous studies and risk models investigating the relationship between risk factors and outcome after cardiac surgery have not included indices of vascular stiffness in their analysis.25–27 However, a recent meta-analysis identified increased PP as a risk factor for development of renal impairment in cardiac surgery patients.28 This is consistent with findings in nonsurgery publications.18,29,30 We used PP as an index of central vascular stiffness in this retrospective review and demonstrated for the first time an independent relationship with the development of focal neurologic deficits. Although this relationship clearly must be tested in a prospective study, the influence of vascular stiffness on outcome attains seminal importance when one considers that vascular stiffness is a modifiable risk factor amenable to intervention.5
We used focal neurologic deficits (as assessed clinically by a neurologist and a majority confirmed with brain imaging) to define stroke in this retrospective study. We did not use measures of neurocognitive decline in this analysis. The rates for stroke development in this patient population are consistent with that outlined in other studies of higher risk populations. Our findings are also consistent with those of other studies that have investigated the relationship between vascular stiffness and neurologic injury. The relationship between hypertension and the subsequent development of cognitive decline, including Alzheimers disease, has been extensively investigated.31–35 Many recent studies investigating the development of neurologic diseases have focused on indices of vascular stiffness and overall vascular health rather than hypertension. Qiu et al36 have demonstrated that higher PPs are associated with an increased risk of Alzheimers disease and dementia in adults >75 years of age. Fujiwara et al37 demonstrated that vascular stiffness as indicated by an increased pulse wave velocity was a potent risk factor for poor cognitive function in community-dwelling elderly individuals. The influence of vascular stiffness on neurologic conditions extends beyond that of cognitive decline in that indices of vascular stiffness have also been shown in a longitudinal study of individuals with no baseline cardiovascular disease or symptoms to be independent predictors of fatal stoke.38 These results in a cohort of outpatients are entirely consistent with our results obtained in the setting of cardiac surgery using cardiopulmonary bypass.
Any 1 or a combination of mechanisms could explain the relationship between vascular stiffness and end-organ damage. Stiff vessels are subject to greater cyclic load with each heart beat compared with compliant vessels, and this is known to exert a greater influence on the vascular smooth muscle cell phenotype.39 The magnitude of the PP may, thus, influence arterial remodeling characteristics in the blood vessels of vital organs.40 Moreover, the influence of stiffness changes on autoregulation in any specific patient and vascular bed are unknown, and efforts to maintain pressure within a generic "autoregulatory range" may be inherently flawed. Although vascular stiffness measurements and PP reflect central vascular properties, stiffness characteristics may also extend to arterioles and vital organs.41 The critical role of cerebral perfusion pressure and cerebral autoregulation is highlighted by the frequency with which watershed infarcts occur after cardiac surgery.42 These clinical and diffusion weighted–MRI-confirmed watershed infarcts were associated with decrements in intraoperative mean arterial pressure of >10 mm Hg and with increased mortality and the need for both short- and long-term care. These decreases in mean arterial pressure were associated with an increased frequency of bilateral watershed infarcts. Moreover, a reduction in diastolic pressure as may occur with early wave reflection will compromise diastolic blood flow augmentation to vital organs. Finally, differential input impedance in the brain and kidney compared with other organs and the exposure of small arterial vessels to high-pressure fluctuations may contribute to the observed pathophysiology in these 2 vital organs.43 Another explanation for our findings might be that vascular stiffness might identify patients with atherosclerosis of the ascending aorta, an important stroke risk factor. In a previous study, when considering the atherosclerosis of the ascending aorta detected with epiaortic ultrasound in multivariable modeling of stroke risk, we found that age was no longer a significant risk predictor of perioperative stroke.44 It should be noted, however, that atheroma burden may not be the most sensitive marker of age-related vascular changes and that even in the absence of atherosclerotic disease and established cardiovascular risk factors, structural and functional changes in the vasculature, eg, stiffness characteristics, accrue with age. These age-related vascular changes have characteristics in common with those that develop in risk factor–induced atherosclerosis, a feature that has delayed the recognition that age, per se, is a cardiovascular risk factor.3
Postmenopausal women have higher vascular stiffness than men of similar age, even after adjusting for body height, blood pressure, and cardiovascular risk.45–48 These findings might be explained in part by the absence of estrogen effects on endothelial function, smooth muscle tone and differentiation, intracellular matrix composition, and the loss of estrogen modulation of vascular inflammation.47,49–54 Our findings of higher PP in women compared with men and the link between PP and stroke are of particular interest in light of our previous findings that women are at higher risk for perioperative stroke than men and that this complication explains a large portion of the higher operative mortality for women.20,44,55 It is possible that sex-related differences in the prevalence of vascular stiffness might contribute to the poor clinical outcomes for women with cardiovascular disease including, possibly, higher mortality and poor neurologic outcomes after cardiac surgery.
The weaknesses of this study include its retrospective nature. Our definition of "neurologic injury" included only focal deficits and did not include changes in neurocognitive indices. We contend, however, that this adds to the validity of our study in that it avoided the limitations inherent in neurocognitive assessments. In addition, all of the recorded strokes occurred within 30 days of surgery although we had longer periods of follow-up data. It is possible that some strokes were misdiagnosed or went unrecorded as the time from surgery increased. We have no reason to believe that the frequency of the later-onset strokes might be greater in patients with lower PP. Indeed, it is more likely that the converse is true, and this would further validate our conclusion. We chose to confine our outcomes to those that were readily quantifiable and about which there might be little disagreement. Moreover, our cohort of patients included those who had coronary artery bypass graft surgery only, as well as those who had coronary artery bypass graft plus valve surgery. Finally, PP is influenced by other variables that were not controlled in this study, eg, severe anemia and aortic incompetence. However, it is unlikely that patients in this setting were allowed to become anemic to a degree that would significantly modulate PP. Almost all of the valve surgeries were performed for mitral regurgitation and/or aortic stenosis, and few for aortic incompetence.
Perspectives
In conclusion, the major new finding of this study is that vascular stiffness, as assessed by PP, is an important age-independent predictor of stroke. Vascular stiffness is rapidly emerging as an age-independent and sensitive predictor of cardiovascular outcomes. Importantly, vascular stiffness indices reflecting central vascular characteristics have been shown to be amenable to reversal, and improvements in these indices are associated with improved cardiovascular outcomes. The results of this study should provide the background for a prospective observational study using more sophisticated measures of vascular stiffness and outcome variables as end points. Furthermore, this provides the impetus for not only incorporating PP into risk stratification, but also encompassing interventions that modify stiffness and thus risk and, as a result, outcome.
| Acknowledgments |
|---|
Funded by departmental funds and in part by NHLBI64600 (C.W.H.) and in part by NIH-R01AGO21523 (D.E.B.).
Disclosures
None.
| Footnotes |
|---|
Received June 4, 2007; first decision June 15, 2007; accepted August 8, 2007.
| References |
|---|
|
|
|---|
2. Mack MJ, Brown PP, Kugelmass AD, Battaglia SL, Tarkington LG, Simon AW, Culler SD, Becker ER. Current status and outcomes of coronary revascularization 1999 to 2002: 148,396 surgical and percutaneous procedures. Ann Thorac Surg. 2004; 77: 761–768.
3. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005; 46: 454–462.
4. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003; 107: 139–146.
5. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005; 25: 932–943.
6. Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006; 113: 664–670.
7. Weber T, Auer J, ORourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004; 109: 184–189.
8. Mitchell GF, Moye LM, Braunwald E, Rouleau J-L, Bernstein V, Geltman EM, Glaker GC, Pfeffer MA. Sphygomomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation. 1997; 96: 4254–4260.
9. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation. 2003; 107: 2864–2869.
10. Dingemans KP, Teeling P, Lagendijk JH, Becker AE. Extracellular matrix of the human aortic media: an ultrastructureal histochemical and immunohistochemical study of the adult aortic media. Anat Rec. 2000; 258: 1–14.[CrossRef][Medline] [Order article via Infotrieve]
11. Waldo KL, Kumiski DH, Kirby ML: Development of the great arteries. In: Living Morphogenesis of the Heart. de la Cruz MV, Markwald RR, eds. Boston, MA: Birkenhauser; 1998: 187–217.
12. Lartaud-Idjouadiene I, Lompre A-M, Kieffer P, Colas T, Atkinson J. Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. Hypertension. 1999; 34: 63–69.[Medline] [Order article via Infotrieve]
13. Roman MJ, Ganau A, Saba PS, Pini R, Pickering TG, Devereux RB. Impact of arterial stiffening on left ventricular structure. Hypertension. 2000; 36: 489–494.
14. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension. 2005; 46: 185–193.
15. Izzo JL Jr, Shykoff BE. Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med. 2001; 2: 29–34.[Medline] [Order article via Infotrieve]
16. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001; 37: 1236–1241.
17. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A, for the Health ABC Study. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005; 111: 3384–3390.
18. Hermans MMH, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CDA. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol. In press.
19. Williams B, Lacy PS, Thorn SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H. Differential impact of blood pressure-lowering drugs on central arterial pressure influences clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006; 113: 1213–1225.
20. Hogue CW, Barzilai B, Pieper KS, Coombs LP, DeLong ER, Kouchoukos. NT, Dávila-Román VG. Sex differences in neurologic outcomes and mortality after cardiac surgery: a Society of Thoracic Surgery National Database Report. Circulation. 2001; 103: 2133–2137.
21. Newman MF, Grocott HP, Mathew JP, White WD, Landolfo K, Reves JG, Laskowitz DT, Mark DB, Blumenthal JA. Report of the substudy assessing impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001; 32: 2874–2881.
22. Roach GW, Kanchuger M, Mora-Mangano C, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C, Ozanne G, Mangano DT. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996; 335: 1857–1863.
23. Wolman RL, Nusssmerier NA, Aggarwal A, Kanchuger MS, Roach GW, Newman MF, Mangano CM, Marschall KE, Ley C, Boisvert DM, Ozanne GM, Herskowitz A, Graham SH, Mangano DT. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Stroke. 1999; 30: 514–522.[Medline] [Order article via Infotrieve]
24. Newman MF, Mathew JP, Grocott HP, Mackensen GB, Monk T, Welsh-Bohmer KA, Blumenthal JA, Laskowitz DT, Mark DB. Central nervous system injury associated with cardiac surgery. Lancet. 2006; 368: 694–703.[CrossRef][Medline] [Order article via Infotrieve]
25. Berman M, Stamler A, Sahar G, Georghiou GP, Sharoni E, Brauner R, Medalion B, Vidne BA, Kogan A. Validation of the 2000 Pernstein-Parsonnet score versus the euroSCORE as a prognostic tool in cardiac surgery. Ann Thorac Surg. 2006; 81: 537–541.
26. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999; 16: 9–13.[Medline] [Order article via Infotrieve]
27. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg. 2000; 69: 823–828.
28. Aronson S, Fontes ML, Miao Y, Mangano DT. Risk index for perioperative renal dysfunction/failure. Circulation. 2007; 115: 733–742.
29. London GM, Marchais SJ, Guerin AP. Arterial stiffness and function in end-stage renal disease. Adv Chronic Kidney Dis. 2004; 11: 202–209.[CrossRef][Medline] [Order article via Infotrieve]
30. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999; 99: 2434–2439.
31. Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Arch Neurol. 2001; 58: 1640–1646.
32. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998; 31: 780–786.
33. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L, Nilsson L, Persson G, Oden A, Svanbory A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347: 1141–1145.[CrossRef][Medline] [Order article via Infotrieve]
34. Launer LJ. Is there epidemiologic evidence that anti-oxidants protect against disorders in cognitive function? J Nutr Health Aging. 2000; 4: 197–201.[Medline] [Order article via Infotrieve]
35. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995; 274: 1846–1851.
36. Qiu C, Winblad B, Viitanen M, Fratiglioni L. Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older. A community-based, longitudinal study. Stroke. 2003; 34: 594–599.
37. Fujiwara Y, Chaves PH, Takahashi R, Amano H, Yoshida H, Kumagai S, Fujita K, Wang DG, Shinkai S. Arterial pulse wave velocity as a marker of poor cognitive function in an elderly community-dwelling population. J Gerontol. 2005; 60: 607–612.
38. Laurent S, Katsahian S, Fassot C, Tropeano A-I, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003; 34: 1203–1206.
39. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science. 1999; 284: 489–493.
40. Boutouyrie B, Bussy C, Lacolley P, Girerd XJ, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation. 1999; 100: 1387–1393.
41. Cohn JN. Arterial stiffness, vascular disease, and risk of cardiovascular events. Circulation. 2006; 113: 601–603.
42. Gottesman RF, Sherman PM, Grega MA, Yousem DM, Borowicz LMJ, Selnes OA, Baumgartner WA, McKhann GM. Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke. 2006; 37: 2306–2311.
43. ORourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005; 46: 200–204.
44. Hogue CWJ, Murphy SF, Schechtman KB, Dávila-Román VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation. 1999; 100: 642–647.
45. Franklin SS, Gustin W, IV, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation. 1997; 96: 308–315.
46. Smulyan H, Asmar RG, Rudnicki A, London GM, Safar ME. Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Card. 2001; 37: 1374–1380.
47. Gatzka CD, Kingwell BA, Camerson JD, Berry KL, Liang YL, Dewar EM, Reid CM, Jennings GL, Dart AM. Gender differences in the timing of arterial wave reflection beyond differences in body height. J Hypertens. 2001; 19: 2197–2203.[CrossRef][Medline] [Order article via Infotrieve]
48. Mitchell GR, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004; 43: 1239–1245.
49. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994; 121: 936–941.
50. Sudhir K, Jennings GL, Funder JW, Komesaroff PA. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension. 1996; 28: 330–334.
51. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996; 28: 576–582.
52. Montague CR, Hunter MG, Gavrilin MA, Phillips GS, Goldschmidt-Clermont PJ, Marsh CB. Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res. 2006; 99: 477–484.
53. Yasmin MC, Wallace S, Dakham Z, Pulsalkar P, Maki-Petaja K, Ashby MJ, Cockcroft JR, Wilkinson IB. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol. 2005; 25: 372–378.
54. Miller AP, Feng W, Xing D, Weathington NM, Blalock E, Chen Y, Oparil S. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation. 2004; 110: 1664–1669.
55. Hogue CW, Sundt T, Barzilai B, Schecthman KB, Davila-Roman VG. Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery. Anesthesiology. 2001; 95: 1074–1078.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
E. Toader, A. Cividjian, and L. Quintin Recruitment of cardiac parasympathetic activity: effects of clonidine on cardiac vagal motoneurones, pressure lability, and cardiac baroreflex slope in rats Br. J. Anaesth., March 1, 2009; 102(3): 322 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nyhan and D. E. Berkowitz Perioperative Blood Pressure Management: Does Central Vascular Stiffness Matter? Anesth. Analg., October 1, 2008; 107(4): 1103 - 1106. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |